• PDF: Delivered by email usually within 48 UK business hours.
  • PRINT/CD-ROM: Despatched within 1 to 2 working days.

IsoRay, Inc. (ISR) - Medical Equipment
Deals and Alliances Profile

  • Publication Date:March 2011
  • Publisher:GlobalData
  • Product Type: Report
  • Pages:25

IsoRay, Inc. (ISR) - Medical Equipment Deals and Alliances Profile

IsoRay, Inc. (ISR) - Medical Equipment - Deals and Alliances Profile

Summary

IsoRay, Inc., (IsoRay) is a publicly traded US-based pharmaceutical company. The company is principally engaged in producing therapeutic medical isotopes for the treatment of prostate cancer and other malignant disease utilizing its radioisotope technology. It is specialized in the development of permanent seed brachytherapy in the treatment of cancers. The company is focused on providing innovative solutions for the treatment and diagnosis of disease using medical isotopes. It has developed cesium-131 (Cs-131) for treatment for all solid tumor applications, including prostate cancer, ocular melanoma, head, neck and lung tumors and breast, liver, brain and pancreatic cancer. The company operates through its subsidiary IsoRay Medical, Inc. Recently the company held a multidisciplinary head and neck cancer symposium. IsoRay is headquartered in Richland, Washington, the US.

IsoRay, Inc. (ISR) - Medical Equipment - Deals and Alliances Profile provides you an in-depth data and trend analysis of the company's mergers and acquisitions (M&A) and financings. The report provides detailed information on M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions registered by the company over a five year period. The report portrays detailed comparative data on the number of deals and their value subdivided by deal types, markets, and regions, besides highlighting the company's major recent financial deals.

Data presented in this report was derived from GlobalData's proprietary in-house Medical Equipment eTrack deals database and primary and secondary research.

Scope

  • Financial Deals - Analysis of the company's financial deals including M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information on the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information on the number of deals and value reported by the company by type such as M&A, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region for North America, Europe, the Middle East and Africa and South and Central America.
  • Deals by Market - Chart and table showing information on the number of deals and value reported by the company, by market.
  • Major Recent Deals - Information on the company's major recent financial deals. Each such deal has a brief summary, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key Competitors - A list of key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements.

  • The profile analyzes the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divesture strategy

  • Deals are presented from the company's core business segments' perspective to help you understand its corporate strategy

Access detailed information about the company's recent financial deals that enables you to understand the key deals which have shaped the company

  • Major recent deals are presented in detail, which provides information on each deal's brief summary, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company to identify potential customers and suppliers.

  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and their biographies and key competitors.

Stay up to date on the major developments affecting the company

  • Recent developments in the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research.

  • Key elements such as break up of deals by categories and information on detailed major deals are incorporated in the profile to assist your academic or business research needs.

This report covers the following industry codes:
SIC Code: 3829
NAICS Code: 334514

  • IsoRay, Inc., Medical Equipment, Deals By Year, 2005 to YTD 2011
    • IsoRay, Inc., Medical Equipment Deals By Type, 2005 to YTD 2011
    • IsoRay, Inc., Medical Equipment, Deals By Region, 2005 to YTD 2011
    • IsoRay, Inc., Medical Equipment, Deals By Market, 2005 to YTD 2011
    • IsoRay, Inc., Medical Equipment, Deals Summary, 2005 to YTD 2011
    • IsoRay, Inc., Medical Equipment, Deal Details
    • Partnerships
    • IsoRay Enters Into Exclusive Licensing Agreement With Hologic
    • IsoRay Enters Into An Agreement With Oncura
    • IsoRay Enters Into Distribution Agreement With Biocompatibles International
    • Equity Offering
    • IsoRay Announces Public Offering Of Common Stock For $4 Million
    • IsoRay Completes Private Placement Of $16.5 Million
    • Key Competitors
    • Key Employees
    • Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
    • Recent Developments
    • Financial Announcements
    • Nov 16, 2010: IsoRay Reports Product Sales Of $1.33 Million For Q1 Fiscal 2011
    • May 12, 2010: IsoRay Reports Product Sales Of $1.2 Million In Q3 Fiscal 2010
    • Feb 16, 2010: IsoRay Reports Net Loss Of $0.9 Million For Q2 Fiscal 2010
    • Nov 16, 2009: IsoRay Reports Product Sales Of $1.4 Million In Q1 Fiscal 2010
    • Sep 24, 2009: IsoRay Reports Revenue Of $5.4 Million For Fiscal 2009
    • May 18, 2009: IsoRay Posts Net Loss Of $1.4 Million For Q3 Fiscal 2009
    • Feb 17, 2009: IsoRay Reports Q2 Fiscal 2009 Results
    • Nov 13, 2008: IsoRay Reports Sales Revenue Of $1.5 Million In Q1 Fiscal 2009
    • Aug 20, 2008: IsoRay Reports 4Q Fiscal 2008 Results
    • May 13, 2008: IsoRay Declares Q3 Fiscal 2008 Results
    • Corporate Communications
    • Jan 27, 2010: IsoRay Appoints William Cavanagh As Vice President Of Research And Development
    • Nov 24, 2008: IsoRay Appoints Vice President, Business Development
    • Product News
    • Jan 21, 2010: IsoRay Announces Implantation Of Cesium-131 At Weill Cornell Medical Center
    • Appendix
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer
  • List of Tables
    • IsoRay, Inc., Medical Equipment, Key Facts, 2009
    • IsoRay, Inc., Medical Equipment, Deals By Year, 2005 to YTD 2011
    • IsoRay, Inc., Medical Equipment, Deals By Region, 2005 to YTD 2011
    • IsoRay, Inc., Medical Equipment, Deals By Market, 2005 to YTD 2011
    • IsoRay, Inc., Medical Equipment, Deals Summary, 2005 to YTD 2011
    • IsoRay, Inc., Medical Equipment, Deals By Year, 2005 to YTD 2011
    • IsoRay, Inc., Medical Equipment Deals By Type, 2005 to YTD 2011
    • IsoRay, Inc., Medical Equipment, Deals By Region, 2005 to YTD 2011
    • IsoRay, Inc., Deals By Market, 2005 to YTD 2011
    • IsoRay, Inc., Medical Equipment, Deals Summary, 2005 to YTD 2011
    • IsoRay Enters Into Exclusive Licensing Agreement With Hologic
    • IsoRay Enters Into An Agreement With Oncura
    • IsoRay Enters Into Distribution Agreement With Biocompatibles International
    • IsoRay Announces Public Offering Of Common Stock For $4 Million
    • IsoRay Completes Private Placement Of $16.5 Million
    • IsoRay, Inc., Key Employees
    • IsoRay, Inc., Subsidiaries
  • List of Figures
    • IsoRay, Inc., Medical Equipment, Deals by Type, 2005 to YTD 2011
    • IsoRay, Inc., Medical Equipment, Deals By Year, 2005 to YTD 2011
    • IsoRay, Inc., Medical Equipment, Deals by Type, 2005 to YTD 2011
    • IsoRay, Inc., Medical Equipment, Deals By Region, 2005 to YTD 2011
    • IsoRay, Inc., Medical Equipment, Deals by Market, 2005 to YTD 2011
+44 20 8816 8548

Ask a question about IsoRay, Inc. (ISR) - Medical Equipment

Enter the characters you see in the picture below
Captcha